Mr. Prabhu D

Mr. Prabhu D

Research Assistant
Department : Research
Email : prabhud2@srmist.edu.in
Prabhu D has completed his bachelor’s in economics (2008) from the University of Madras, Chennai. He did Diploma in Medical Lab Technology (DMLT) in 2011 and Laboratory Animal Technician Training Course in 2012. He has 10 years of experience in Department of Cell and Molecular Biology, Madras Diabetes Research Foundation, Chennai as Animal House Supervisor. He has joined SRM Medical College Hospital and Research Center in 2021 and has been with the Faculty of Medical & Health Sciences, SRM Institute of Science & Technology, Kattankulathur campus as Research Assistant.

CAMPUS: Allied Health Sciences, Medicine & Health Sciences, Kattankulathur - Chennai

Top 5 publications

  • Kuppan Gokulakrishna, Gautam Kumar Pandey, Chandrakumar Sathishkumar, Saravanakumar Sundararajan, Prabhu Durairaj, Nagaraj Manickam, Viswanathan Mohan, Muthuswamy Balasubramanyam – “Augmentation of RBP4/STRA6 signaling leads to insulin resistance and inflammation and the plausible therapeutic role of vildagliptin and metformin”. Mol Biol Rep. 2021, May;48(5):4093-4106 (IF- 2.742).
  • Sathishkumar C, Prabu P, Balakumar M, Lenin R, Prabhu D, Anjana RM, Mohan V, Balasubramanyam M. – “Augmentation of histone deacetylase 3 (HDAC3) epigenetic signature at the interface of proinflammation and insulin resistance in patients with type 2 diabetes”. Clin Epigenetics. 2016 Nov 24; 8:125, (IF- 7.259).
  • Balakumar M, Prabhu D, Sathishkumar C, Prabu P, Rokana N, Kumar R, Raghavan S, Soundarajan A, Grover S, Batish VK, Mohan V, Balasubramanyam M – Improvement in glucose tolerance and insulin sensitivity by probiotic strains of Indian gut origin in high-fat diet-fed C57BL/6J mice. Eur J Nutr. 2016 Oct 18, (IF- 4.865).
  • Balakumar M, Raji L, Prabhu D, Sathishkumar C, Prabu P, Mohan V, Balasubramanyam M – High-fructose diet is as detrimental as high-fat diet in the induction of insulin resistance and diabetes mediated by hepatic/pancreatic endoplasmic reticulum (ER) stress. Mol Cell Biochem. 2016 Dec; 423(1-2):93-104. (IF- 3.842).
  • Jayashree , Y. S. Bibin , D. Prabhu , C. S. Shanthirani , K. Gokulakrishnan , B. S. Lakshmi, V. Mohan, M. Balasubramanyam – Increased circulatory levels of lipopolysaccharide (LPS) and zonulin signify novel biomarkers of proinflammation in patients with type 2 diabetes. Mol Cell Biochem DOI 10.1007/s11010-013-1911-4. (IF-3.842)
Research & Publications :

Top 5 publications

  • Kuppan Gokulakrishna, Gautam Kumar Pandey, Chandrakumar Sathishkumar, Saravanakumar Sundararajan, Prabhu Durairaj, Nagaraj Manickam, Viswanathan Mohan, Muthuswamy Balasubramanyam – “Augmentation of RBP4/STRA6 signaling leads to insulin resistance and inflammation and the plausible therapeutic role of vildagliptin and metformin”. Mol Biol Rep. 2021, May;48(5):4093-4106 (IF- 2.742).
  • Sathishkumar C, Prabu P, Balakumar M, Lenin R, Prabhu D, Anjana RM, Mohan V, Balasubramanyam M. – “Augmentation of histone deacetylase 3 (HDAC3) epigenetic signature at the interface of proinflammation and insulin resistance in patients with type 2 diabetes”. Clin Epigenetics. 2016 Nov 24; 8:125, (IF- 7.259).
  • Balakumar M, Prabhu D, Sathishkumar C, Prabu P, Rokana N, Kumar R, Raghavan S, Soundarajan A, Grover S, Batish VK, Mohan V, Balasubramanyam M – Improvement in glucose tolerance and insulin sensitivity by probiotic strains of Indian gut origin in high-fat diet-fed C57BL/6J mice. Eur J Nutr. 2016 Oct 18, (IF- 4.865).
  • Balakumar M, Raji L, Prabhu D, Sathishkumar C, Prabu P, Mohan V, Balasubramanyam M – High-fructose diet is as detrimental as high-fat diet in the induction of insulin resistance and diabetes mediated by hepatic/pancreatic endoplasmic reticulum (ER) stress. Mol Cell Biochem. 2016 Dec; 423(1-2):93-104. (IF- 3.842).
  • Jayashree , Y. S. Bibin , D. Prabhu , C. S. Shanthirani , K. Gokulakrishnan , B. S. Lakshmi, V. Mohan, M. Balasubramanyam – Increased circulatory levels of lipopolysaccharide (LPS) and zonulin signify novel biomarkers of proinflammation in patients with type 2 diabetes. Mol Cell Biochem DOI 10.1007/s11010-013-1911-4. (IF-3.842)